NPs Basic Information

Name
Genistin
Molecular Formula C21H20O10
IUPAC Name*
5-hydroxy-3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
SMILES
C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O
InChI
InChI=1S/C21H20O10/c22-7-15-18(26)19(27)20(28)21(31-15)30-11-5-13(24)16-14(6-11)29-8-12(17(16)25)9-1-3-10(23)4-2-9/h1-6,8,15,18-24,26-28H,7H2/t15-,18-,19+,20-,21-/m1/s1
InChIKey
ZCOLJUOHXJRHDI-CMWLGVBASA-N
Synonyms
Genistin; 529-59-9; Genistoside; Genistine; Genistein 7-glucoside; Genistein glucoside; Genisteol 7-monoglucoside; Genistein 7-O-beta-D-glucoside; NSC 5112; Glucosyl-7-genistein; CHEBI:27514; genistein 7-O-glucoside; 1POG3SCN5T; 5-hydroxy-3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; Genistein, 7-O-beta-D-glucoside; 4',5,7-trihydroxyisoflavone 7-D-glucoside; Genistein, 7-beta-D-glucopyranoside; Isoflavone, 4',5,7-trihydroxy-, 7-D-glucoside; 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside; 5-hydroxy-3-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one; 4',5,7-Trihydroxyisoflavone 7-.beta.-D-glucopyranoside; 4',5,7-Trihydroxyisoflavone 7-glucoside; UNII-1POG3SCN5T; Glucopyranoside, genistein-7, beta-D-; BRN 0064479; NSC-5112; 7-O-.beta.-D-glucopyranosyl genistein; Genistein glycoside; Genistin,(S); 5-hydroxy-3-(4-hydroxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one; MFCD00016883; GENISTIN [USP-RS]; SCHEMBL62148; Genistin, analytical standard; 4-18-00-02732 (Beilstein Handbook Reference); MLS006010735; BIDD:ER0520; CHEMBL486625; MEGxp0_000436; GENISTEIN GENISTIN [MI]; DTXSID3022324; ACon1_001495; Genistin - CAS 529-59-9; Genistin, >=97.5% (TLC); Genistein 7-O-b-D-glucopyranoside; HY-N0595; ZINC4097913; BDBM50025609; AKOS025146960; CCG-208377; CS-4240; 4H-1-Benzopyran-4-one, 7-(beta-D-glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-; NCGC00163559-01; NCGC00163559-02; NCGC00180447-01; AS-11684; SMR003929926; G0358; C09126; GENISTEIN 7-O-.BETA.-D-GLUCOPYRANOSIDE; Genistin, primary pharmaceutical reference standard; Q-100603; Q5533221; BRD-K51391729-001-01-4; GENISTIN (CONSTITUENT OF SOY ISOFLAVONES) [DSC]; Genistin, from Glycine max (soybean), >=95% (HPLC); 5,4'-DI-HYDROXYISOFLAVONE-7-O-.BETA.-D-GLUCOPYRANOSIDE; Genistin, United States Pharmacopeia (USP) Reference Standard
CAS 529-59-9
PubChem CID 5281377
ChEMBL ID CHEMBL486625
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Phenylpropanoids and poly
      • Class: Isoflavonoids
        • Subclass: Isoflavonoid O-glycosides
          • Direct Parent: Isoflavonoid O-glycosides

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 432.4 ALogp: 0.9
HBD: 6 HBA: 10
Rotatable Bonds: 4 Lipinski's rule of five: Rejected
Polar Surface Area: 166.0 Aromatic Rings: 4
Heavy Atoms: 31 QED Weighted: 0.34

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -6.314 MDCK Permeability: 0.00000949
Pgp-inhibitor: 0.005 Pgp-substrate: 0.486
Human Intestinal Absorption (HIA): 0.282 20% Bioavailability (F20%): 0.007
30% Bioavailability (F30%): 0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.032 Plasma Protein Binding (PPB): 93.41%
Volume Distribution (VD): 0.751 Fu: 5.36%

ADMET: Metabolism

CYP1A2-inhibitor: 0.234 CYP1A2-substrate: 0.045
CYP2C19-inhibitor: 0.037 CYP2C19-substrate: 0.055
CYP2C9-inhibitor: 0.052 CYP2C9-substrate: 0.443
CYP2D6-inhibitor: 0.508 CYP2D6-substrate: 0.23
CYP3A4-inhibitor: 0.094 CYP3A4-substrate: 0.027

ADMET: Excretion

Clearance (CL): 3.061 Half-life (T1/2): 0.755

ADMET: Toxicity

hERG Blockers: 0.158 Human Hepatotoxicity (H-HT): 0.065
Drug-inuced Liver Injury (DILI): 0.68 AMES Toxicity: 0.577
Rat Oral Acute Toxicity: 0.07 Maximum Recommended Daily Dose: 0.008
Skin Sensitization: 0.743 Carcinogencity: 0.414
Eye Corrosion: 0.003 Eye Irritation: 0.221
Respiratory Toxicity: 0.028
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC004476 0.771 D0TC7C 0.401
ENC004734 0.571 D06BQU 0.396
ENC001532 0.569 D0I9HF 0.378
ENC001550 0.560 D08DFX 0.373
ENC004797 0.520 D01TNW 0.367
ENC001572 0.508 D06ALD 0.359
ENC001771 0.495 D0K8KX 0.327
ENC002201 0.480 D0AZ8C 0.324
ENC004073 0.454 D04AIT 0.309
ENC001575 0.454 D09LBS 0.306
*Note: the compound similarity was calculated by RDKIT.